Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Sierra Internal Medicine
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Daniel Peterson== The [[1984 Incline Village chronic fatigue syndrome outbreak]] affected many patients in the Incline Village area. Since that date, Dr [[Daniel Peterson|Daniel L. Peterson]], began specializing in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]] (ME/CFS).<ref>{{Cite news | url=http://www.cortjohnson.org/chronic-fatigue-syndrome-mecfs-doctor-resource-center/dr-dan-peterson-sierra-internal-medicine-incline-village-nevada/ | title = Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising|work=Health Rising|access-date=2018-08-13|language=en-US}}</ref><ref name="Strayer,1995">{{Cite journal | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | last2 = Carter | first2 = W | authorlink2 = William Carter | last3 = Strauss | first3 = KI | authorlink3 = Kenneth Strauss | last4 = Brodsky | first4 = I | authorlink4 = | last5 = Suhadolnik | first5 = R | authorlink5 =Robert Suhadolnik | last6 = Ablashi | first6 = D | authorlink6 = Dharam Ablashi | last7 = Henry | first7 = B | authorlink7 = | last8 = Mitchell | first8 = WM | authorlink8 = William Mitchell | last9 = Bastien | first9 = S | authorlink9 =Sheila Bastien | last10 = Peterson | first10 = D | authorlink10 = Daniel Peterson| title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen| journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | date = 1995 | doi = 10.1300/J092v01n01_04 | url= }}</ref><ref name="Strayer, 2012">{{Cite journal | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | last2 = Carter | first2 = WA | authorlink2 = William Carter | last3 = Stouch | first3 = BC | authorlink3 = | last4 = Stevens | first4 = SR | authorlink4 = Staci Stevens | last5 = Bateman | first5 = L | authorlink5 = Lucinda Bateman | last6 = Cimoch | first6 = PJ | authorlink6 = | last7 = Lapp | first7 = CW | authorlink7 =Charles Lapp | last8 = Peterson | first8 = DL | authorlink8 = Daniel Peterson | last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | last10 = Mitchell | first10 = WM | authorlink10 = William Mitchell | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | date = 2012 | pmid = 22431963 | doi = 10.1371/journal.pone.0031334}}</ref> Dr Peterson continues to be a leader in [[ME/CFS]] treatment and research and serves on the Scientific Advisory Boards at [[Simmaron Research]], the Faculty of Health Sciences and Medicine at [[Griffith University]] in Queensland, Australia, and the [[Open Medicine Foundation]].<ref name="OMF-profile">{{Cite web|url=https://www.omf.ngo/people/daniel-l-peterson-md/ | title = Daniel L. Peterson, MD|website=Open Medicine Foundation|language=en-US|access-date=2019-04-01}}</ref><ref>{{Cite news | url=http://simmaronresearch.com/collaborative-research/ | title = Collaborators - Simmaron Research|work=Simmaron Research|access-date=2018-08-13|language=en-US}}</ref> He has been based at Sierra Internal Medicine since 2010.<ref name="trial-history">{{Cite web|url=https://clinicaltrials.gov/ct2/history/NCT00215813?V_5=View#StudyPageTop | date = 2010-04-08 | title = History of Changes for Study: NCT00215813 {{!}} Study of Ampligen in Chronic Fatigue Syndrome | website = ClinicalTrials.gov|access-date=2020-04-13}}</ref> {{See also|Ampligen}}
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs